2017 Annual Meeting

Session: Model Based Integrated Design of Pharmaceutical Drug Product Processes

session seeks contributions where modeling-aided approaches as well as optimization techniques have been applied for decision making in the design and development of pharmaceutical intermediates, and/or drug products. Modeling research using deterministic models derived from fundamental principles are all in scope for this session. Authors are encouraged to highlight integration to upstream and downstream operations as well as Quality by Design considerations.

Chair

Brendon G. Ricart, Merck & Co., Inc.

Co-Chair

Nima Yazdanpanah, Food and Drug Administration

Presentations

12:30 PM

Pongpumin Bunchatheeravate, Joseph W. Bullard, Steven Dale, Greg Connelly, Marcus O'Mahony

12:52 PM

Bernd Van Snick, Valérie Vanhoorne, Maxim Verstraeten, Jens Dhondt, Giustino Di Pretoro, Thomas De Beer, Chris Vervaet

01:14 PM

M. Sebastian Escotet-Espinoza, Glinka Cathy Pereira, Andres Roman-Ospino, Fernando Muzzio, Marianthi Ierapetritou

01:36 PM

Pedro Valente, João Vicente, João Henriques, Tiago Porfirio, Márcio Temtem, Slavomira Doktorovova, Nuno Enes, Paulo Lino, Inês Lopes, Nuno Neves, Mafalda Paiva

01:58 PM

Charalampos Christodoulou, Eva Sørensen, Salvador Garcia-Munoz, Luca Mazzei

02:20 PM

02:42 PM

Brian Glennon, Yuan Gao, Yunliang He, Guangyang Hou, Philip Donnellan